Mauro David J 4
4 · Codiak BioSciences, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-24+190,000→ 190,000 totalExercise: $0.74Exp: 2033-01-23→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.